XENON PHARMACEUTICALS INC's ticker is and the CUSIP is 98420N905. A total of 3 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,058 | +541.2% | 31,000 | +620.9% | 0.00% | – |
| Q2 2023 | $165 | -91.0% | 4,300 | -91.6% | 0.00% | -100.0% |
| Q1 2023 | $1,828 | -42.7% | 51,100 | -36.9% | 0.00% | -33.3% |
| Q4 2022 | $3,193 | -92.6% | 81,000 | +6650.0% | 0.00% | – |
| Q3 2022 | $43,000 | -63.6% | 1,200 | -69.2% | 0.00% | – |
| Q2 2022 | $118,000 | +34.1% | 3,900 | +34.5% | 0.00% | – |
| Q1 2022 | $88,000 | -91.0% | 2,900 | -90.7% | 0.00% | -100.0% |
| Q4 2021 | $974,000 | +4327.3% | 31,200 | +2500.0% | 0.00% | – |
| Q3 2021 | $22,000 | +57.1% | 1,200 | +50.0% | 0.00% | – |
| Q2 2021 | $14,000 | +16.7% | 800 | +11328.6% | 0.00% | – |
| Q1 2021 | $12,000 | +300.0% | 7 | +133.3% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 3 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -70.0% | 3 | -70.0% | 0.00% | – |
| Q1 2019 | $10,000 | +66.7% | 10 | +100.0% | 0.00% | – |
| Q3 2018 | $6,000 | +50.0% | 5 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $4,000 | 0.00% |
| SIMPLEX TRADING, LLC | 1,200 | $43,000 | 0.00% |